NCT06292741 Autonomic Involvement in Patient With Cognitive Decline
| NCT ID | NCT06292741 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Dementia, Mild |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-01-11 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-01-11 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective interventional study with a device for comparing autonomic parameters among patients with different forms of cognitive decline
Eligibility Criteria
Inclusion Criteria: * male and females between 50 and 85 years * cognitive decline (dementia, lewy's body dementia, Parkinson dementia, Alzheimer dementia) * mild cognitive decline ( lewy's body MCI, Parkinson MCI and Alzheimer MCI) * Ability to assume the upright position Exclusion Criteria: * diabetes mellitus * eye problems * severe cognitive decline * heart disease * peripheral neuropathy * language barrier * oncological disease * medical pathologies associated with cognitive deficits
Contact & Investigator
Camillo Marra, MD
PRINCIPAL INVESTIGATOR
Memory clinic- Policlinico Agostino Gemelli, IRCCS, Università Cattolica del Sacro Cuore I
Frequently Asked Questions
Who can join the NCT06292741 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Dementia, Mild. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06292741 currently recruiting?
Yes, NCT06292741 is actively recruiting participants. Contact the research team at camillo.marra@policlinicogemelli.it for enrollment information.
Where is the NCT06292741 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06292741 clinical trial?
NCT06292741 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Camillo Marra, MD at Memory clinic- Policlinico Agostino Gemelli, IRCCS, Università Cattolica del Sacro Cuore I. The trial plans to enroll 120 participants.